BA
44
2
ECL
82
3
ES
38
4
GME
65
2
NSC
50
2
HSY
54
-3
PGR
62
-2
STT
39
-9
DE
32
9
PYPL
24
-15
WFC
63
13
SYK
62
5
CPB
40
-2
TSCO
60
-2
STI
40
37
OKE
59
3
NKE
39
2
LYB
34
2
GOOG
57
-10
AON
32
13
BA
44
2
ECL
82
3
ES
38
4
GME
65
2
NSC
50
2
HSY
54
-3
PGR
62
-2
STT
39
-9
DE
32
9
PYPL
24
-15
WFC
63
13
SYK
62
5
CPB
40
-2
TSCO
60
-2
STI
40
37
OKE
59
3
NKE
39
2
LYB
34
2
GOOG
57
-10
AON
32
13
Financhill
Back

AbbVie Vs. Perficient Industry Stock Comparison

Sell
50

ABBV
AbbVie

Last Price:
155.33
Seasonality Move:
-0.5%
Buy
69

PRFT
Perficient

Last Price:
73.80
Seasonality Move:
0.21%
Sell
50
AbbVie (ABBV) is a Sell

Is AbbVie a Buy, Sell or Hold?

  • The current AbbVie [ABBV] share price is $157.06. The Score for ABBV is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
  • ABBV is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
69
Perficient (PRFT) is a Buy

Is Perficient a Buy, Sell or Hold?

  • The current Perficient [PRFT] share price is $73.81. The Score for PRFT is 69, which is 38% above its historic median score of 50, and infers lower risk than normal.
  • PRFT is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

ABBV Stock Price Chart

What is AbbVie's stock price today?

  • The AbbVie share price today is $157.06
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ABBV is experiencing slight selling pressure.

PRFT Stock Price Chart

What is Perficient's stock price today?

  • The Perficient share price today is $73.81
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PRFT is experiencing slight buying pressure.

ABBV Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.93 Sell
Relative Strength Index (14 RSI): 34.32 Sell
Chaikin Money Flow: -1518828 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (159.69 - 165.85) Sell
Bollinger Bands (100): (162.22 - 176.92) Sell

PRFT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 5.58 Buy
Relative Strength Index (14 RSI): 78.85 Buy
Chaikin Money Flow: 76419 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (48.65 - 76.17) Buy
Bollinger Bands (100): (52.84 - 72) Buy

ABBV Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 162.12 Sell
20-day SMA: 161.86 Sell
50-day SMA: 167.86 Sell
200-day SMA: 158.57 Sell
8-day EMA: 160.65 Sell
20-day EMA: 162.42 Sell
50-day EMA: 165.62 Sell
200-day EMA: 160.92 Sell

PRFT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 73.71 Buy
20-day SMA: 66.94 Buy
50-day SMA: 57.8 Buy
200-day SMA: 61.8 Buy
8-day EMA: 73.08 Buy
20-day EMA: 67.92 Buy
50-day EMA: 62.48 Buy
200-day EMA: 63.79 Buy

AbbVie Earnings Growth & ABBV Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.04 per share, an increase next quarter of $0.20 per share, an increase this year of $0.10 per share, and an increase next year of $0.83 per share.

Perficient Earnings Growth & PRFT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.15 per share, a decrease next quarter of $0.04 per share, a decrease this year of $0.04 per share, and an increase next year of $0.45 per share.

AbbVie Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Perficient Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):